Our conclusion from these studies is that cancer cells undergoing TGF‐β‐induced EMT adopt features of immune cells and that the term ‘mesenchymal’ actually is insufficient to describe the properties of EMT cells. The gene discussed is TGFB1; the disease is cancer.